GlassScriptPhysician profile
Freddie D Persinger
NPI 1104145135
$6,704.34
in general payments reported to CMS, 2019-2025
29 companies · $58.11 in 2025
The $58.11 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $3,960 · 2021: $588 · 2022: $385 · 2023: $953 · 2024: $545 · 2025: $58.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,119 · Travel and Lodging: $292 · Education: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,118.79 |
| Travel and Lodging | $291.96 |
| Education | $145.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,841.12 | 2020 | |
| Zimmer Biomet Holdings, INC. | $1,455.74 | 2019-2024 | Persona, Rosa, Comprehensive Shoulder System |
| Mid-Atlantic Surgical Systems, LLC | $807.96 | 2020-2024 | |
| Abbott Laboratories | $373.46 | 2020-2024 | Proclaim |
| Stryker Corporation | $256.25 | 2021-2022 | |
| Organogenesis INC. | $206.95 | 2023 | Puraply |
| Bioventus LLC | $121.77 | 2020-2025 | Gelsyn-3, Exogen Ultrasound Bone Healing System |
| Vericel Corporation | $73.80 | 2020-2021 | |
| Smith+Nephew, INC. | $61.11 | 2021-2024 | Pico 7 |
| Pacira Therapeutics, INC. | $55.04 | 2020-2021 | |
| Ferring Pharmaceuticals INC. | $46.45 | 2019-2025 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $43.03 | 2023-2024 | Exparel, Iovera, Zilretta |
| Treace Medical Concepts, INC. | $41.50 | 2022 | |
| Convatec INC. | $29.52 | 2023-2024 | |
| Cardinal Health 200 LLC | $26.32 | 2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $25.98 | 2024 | V.A.C.Ulta, Prevena |
| Medela LLC | $22.54 | 2020 | |
| Endo Pharmaceuticals INC. | $22.18 | 2022 | |
| Endo USA, INC. | $21.84 | 2025 | Xiaflex |
| Linvatec Corporation | $21.40 | 2021 | |
| Orthofix Medical, INC. | $20.93 | 2019 | |
| Molnlycke Health Care US, LLC | $20.39 | 2021 | |
| Kci USA, INC. | $18.35 | 2023 | Prevena, V.A.C. Veraflo, Activ.A.C. |
| Encore Medical, LP | $17.39 | 2023 | Djo Surgical |
| Horizon Therapeutics Plc | $17.03 | 2021 | |
| Nevro Corp. | $14.61 | 2024 | Senza |
| Davol INC. | $14.44 | 2021 | |
| Sonex Health, INC. | $13.67 | 2020 | |
| Heron Therapeutics, INC. | $13.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Freddie Persinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.